<DOC>
	<DOCNO>NCT01839695</DOCNO>
	<brief_summary>The Valiant Mona LSA thoracic stent graft system endovascular repair aneurysm descend thoracic aorta ( DTA ) patient require coverage leave subclavian artery ( LSA ) .The study intend assess safety performance device acutely 30 day .</brief_summary>
	<brief_title>Safety Efficacy Valiant Mona LSA Stent Graft System</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Thoracic</mesh_term>
	<criteria>Subject least 18 year age . The subject legal guardian understand nature study agree provision write informed consent form Subject must consider candidate revascularization LSA . Subject DTA require coverage LSA Subject 's anatomy must meet anatomical criterion receive implant device Subject previous endovascular repair ascend and/or descend thoracic aorta . Subject acute renal failure renal insufficiency serum creatinine â‰¥ 2.0 mg/dL Subject pregnant female . Enrollment another clinical study Subject cerebral vascular accident ( CVA ) myocardial infarction ( MI ) within 3 month . Subject history bleeding diathesis , coagulopathy , refuse blood transfusion . Subject know allergy intolerance device component . Subject know hypersensitivity contraindication anticoagulant contrast medium , amenable pretreatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Thoracic Aneurysm</keyword>
	<keyword>Endovascular Aortic Repair</keyword>
	<keyword>TEVAR</keyword>
</DOC>